Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

MABF848 Anti-EBI3 Antibody/IL-35, clone V1.4C4.22 (Neutralizing)

MABF848
100 µg  
Purchase on Sigma-Aldrich

Oferty specjalne

Przegląd

Replacement Information

Oferty specjalne

Tabela kluczowych gatunków

Species ReactivityKey ApplicationsHostFormatAntibody Type
MWB, NEUTMPurifiedMonoclonal Antibody
Description
Catalogue NumberMABF848
DescriptionAnti-EBI3 Antibody/IL-35, clone V1.4C4.22 (Neutralizing)
Alternate Names
  • EBI3/IL-35
  • IL-27B
  • Interleukin-27 subunit beta
  • IL-27 subunit beta
  • IL-27B
  • Epstein-Barr virus-induced gene 3 protein homolog
Background InformationEBI3/IL27B is the beta subunit of the functional cytokine IL-27. The beta subunit is required for activity. IL-27 is a critical cytokine of mammalian innate immune response. IL-27 has both pro and anti-inflammatory activities. IL-27 regulates T-helper cell development and differentiation into TH1, TH2 and TH17 effector cells. IL-27 also is important in isotype switching for B-cells, and it drives rapid clonal expansion of native but not memory CD4 cells. IL-27 is also important for its anti-tumor and anti-angiogenic activity on tumor and cancer cells. The beta subunit EBI3/IL27B is also a component of IL-35 which is a heterodimer of IL-12alpha and IL-27B/EBI3. IL-35 plays a role in immune suppression. IL-27 is a secreted cytokine, thus IL-27beta subunit is expressed intracellularly associated with the endoplasmic reticulum and membrane vesicles and is detected extracellularly as part of the mature cytokine as well.
References
Product Information
FormatPurified
PresentationPurified mouse monoclonal IgG2bκ in buffer containing PBS without preservatives.
Quality LevelMQ100
Applications
ApplicationAnti-EBI3 Antibody/IL-35, clone V1.4C4.22 (Neutralizing) is an antibody against EBI3 /IL-35 for use in Western Blotting, Neutralizing.
Key Applications
  • Western Blotting
  • Neutralizing
Application NotesNeutralizing Analysis: A representative lot detected EBI3/IL-35 during in-vitro neutralizing (Collison, L.W., et al. (2010). Nat Immunol. 11(12):1093-1101).
Biological Information
ImmunogenRecombinant protein corresponding to mouse EBI3/IL-35.
CloneV1.4C4.22
ConcentrationPlease refer to lot specific datasheet.
HostMouse
SpecificityClone V1.4H6.25 (MABF836) was used in in-vitro mIL-35 neutralizing studies and clone V1.4C4.22 (MABF848) was used in in-vivo mIL-35 neutralizing studies (Collison, L.W., et al. (2010). Nat Immunol. 11(12):1093-1101).
IsotypeIgG2bκ
Species Reactivity
  • Mouse
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Gene Symbol
  • Ebi3
  • Il27b
Purification MethodProtein G Purified
UniProt Number
Molecular Weight~25 kDa observed
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceEvaluated by Western Blotting in recombinant m-EBI3/IL-27.

Western Blotting Analysis: 0.5 µg/mL of this antibody detected EBI3/IL-35 in 1 µg of recombinant m-EBI3/IL-27.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at -20°C from date of receipt.
Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
Packaging Information
Material Size100 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Numer katalogowy GTIN
MABF848 04055977135381

Documentation

Anti-EBI3 Antibody/IL-35, clone V1.4C4.22 (Neutralizing) MSDS

Title

Safety Data Sheet (SDS) 

Anti-EBI3 Antibody/IL-35, clone V1.4C4.22 (Neutralizing) Certificates of Analysis

TitleLot Number
Anti-EBI3/IL-35, clone V1.4C4.22 (Neutralizing) - 3026051 3026051
Anti-EBI3/IL-35, clone V1.4C4.22 (Neutralizing) - 3167566 3167566
Anti-EBI3/IL-35, clone V1.4C4.22 (Neutralizing) - 3268886 3268886
Anti-EBI3/IL-35, clone V1.4C4.22 (Neutralizing) - 3429029 3429029
Anti-EBI3/IL-35, clone V1.4C4.22 (Neutralizing) - 3907876 3907876
Anti-EBI3/IL-35, clone V1.4C4.22 (Neutralizing) - 4094584 4094584
Anti-EBI3/IL-35, clone V1.4C4.22 (Neutralizing) Monoclonal Antibody 3117564
Anti-EBI3/IL-35, clone V1.4C4.22 (Neutralizing) Monoclonal Antibody 3109704
Anti-EBI3/IL-35, clone V1.4C4.22 -Q2550837 Q2550837

References

Reference overviewPub Med ID
Nature immunology
Collison, LW; Chaturvedi, V; Henderson, AL; Giacomin, PR; Guy, C; Bankoti, J; Finkelstein, D; Forbes, K; Workman, CJ; Brown, SA; Rehg, JE; Jones, ML; Ni, HT; Artis, D; Turk, MJ; Vignali, DA
Nature immunology  11  1093-101  2009

Pokaż streszczenie
20953201 20953201

Brochure

Title
NPI Flyer- Epigenetics and Nuclear Function Feature
New Products - Antibodies, Small Molecule, Inhibitors

Technical Info

Title
White Paper: Further considerations of antibody validation and usage.